Medregen has initiated its proof of concept, phase II study ‘Safety and Efficacy of MRG-001 in Wound Healing and Scar Appearance in Pre-Abdominoplasty Surgical Excisions’ in collaboration with the department of surgery, division of plastic and reconstructive surgery at the Northwestern University Feinberg School of Medicine. In total 10 subjects (5 MRG-001 and 5 Placebo) will be recruited to the study.
15
Dec
